Daryl Hagan
Papers
2
Total Citations
322
H-Index
2
About
Daryl Hagan is a leading urologic surgeon and researcher whose work is reshaping the surgical management of bladder cancer. His primary research focus lies in the comparative effectiveness of robot-assisted versus open radical cystectomy, with a particular emphasis on improving postoperative recovery and reducing morbidity. Hagan’s most significant contribution is his landmark 2022 study, “Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer,” which has garnered over 320 citations. This pivotal work provided critical evidence from the IROC multi-centre randomised trial, demonstrating that total intracorporeal robotic surgery can enhance recovery outcomes compared to traditional open procedures. By systematically evaluating recovery metrics and complication rates, Hagan has helped clarify the role of minimally invasive techniques in a high-stakes surgical setting. His research directly informs clinical decision-making, offering surgeons and patients a clearer understanding of the trade-offs between robotic and open approaches. Through rigorous trial design and high-impact publications, Hagan continues to drive innovation in urologic oncology, making him a key figure in the ongoing evolution of bladder cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2